| Identification | |
| Name: | Acetamide,N-[2,4-dimethyl-5-[[(trifluoromethyl)sulfonyl]amino]phenyl]- |
| Synonyms: | 5-Acetamido-2,4-dimethyltrifluoromethanesulfonanilide;Embark; Embark 2S; MBR 12325; Mefluidide; Trim-Cut; VEL 3973; Vistar |
| CAS: | 53780-34-0 |
| EINECS: | 258-767-4 |
| Molecular Formula: | C11H13 F3 N2 O3 S |
| Molecular Weight: | 310.32 |
| InChI: | InChI=1/C11H13F3N2O3S/c1-6-4-7(2)10(5-9(6)15-8(3)17)16-20(18,19)11(12,13)14/h4-5,16H,1-3H3,(H,15,17) |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.464g/cm3 |
| Refractive index: | 1.539 |
| Solubility: | Solubility at 25 deg C (g/L): benzene 0.31; dichloromethane 2.1; 1-octanol 17; methanol 310; acetone 350 In water, 180 mg/L at 23 deg C |
| Specification: |
The adverse reaction caused by 2′,4′-Dimethyl-5-((trifluoromethyl)-sulfonamido)acetanilide (CAS NO.53780-34-0) was weight loss, eye, kidney, liver, sciatic nerve and spleen impacted. |
| Color: | Crystalline solid |
| Safety Data | |
 |
|
